Stock Report

All about this stock under one free report Last Updated: 08-Oct-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Granules India Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: GRANULES | BSE: 532482

₹815.90

up-down-arrow ₹-29.40 (-3.48%)

As on 08-Oct-2026 14:49IST

Market cap

info icon

₹22,543 Cr

Revenue (TTM)

info icon

₹5,632 Cr

P/E Ratio

info icon

34

P/B Ratio

info icon

4.6

Div. Yield

info icon

0.2 %

Edit peer-selector-edit
Granules India Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Market cap (₹ Cr)
 22,543 33,440 25,454 26,367 24,993
Revenue (₹ Cr)
 5,632 3,564 1,936 9,205 1,462
Net Profit (₹ Cr)
 662.35 414.00 288.22 -371.81 387.35
Net Margin (%)
 11.75 11.23 14.79 -3.93 26.01
RoE (%)
 14.34 8.38 29.77 -3.85 25.18
Price to Earnings
 34.03 81.76 88.32 -- 64.71
Price-To-Book
 4.60 6.64 18.96 3.29 14.49

Income Statement (₹ Cr)

Granules India Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Operating Revenue arrow
5,632.31 3,564.00 1,935.80 9,205.28 1,461.80
Total Income arrow
5,638.56 3,686.00 1,948.58 9,449.59 1,489.25
Total Expenditure arrow
4,354.97 2,792.00 1,485.56 8,195.15 919.25
EBITDA arrow
1,277.34 772.00 450.24 1,010.13 542.56
Depreciation arrow
306.94 226.00 50.83 857.51 37.68
EBIT arrow
970.39 546.00 399.41 152.62 504.88
Interest arrow
111.70 217.00 40.84 342.73 3.77
Other Income arrow
6.25 122.00 12.78 244.31 27.45
Exceptional Items arrow
15.92 12.00 0.00 -216.88 0.00
Profit before Tax arrow
880.86 463.00 371.35 -162.68 528.56
Provision for Tax arrow
218.51 49.00 83.14 209.13 141.21
Profit after Tax arrow
662.35 414.00 288.22 -371.81 387.35

Liabilities (₹ Cr)

Granules India Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Shareholder's Funds arrow
5,085.00 4,940.00 1,288.82 8,162.62 1,653.56
Minority Interest arrow
0.00 -5.00 0.00 0.00 -1.13
Non-Current Liabilities arrow
542.92 1,712.00 202.03 5,044.14 42.40
Current Liabilities arrow
2,092.03 1,622.00 835.87 4,758.28 230.82
Total Liabilities arrow
7,682.91 8,578.00 2,326.71 17,723.32 1,983.96

Assets (₹ Cr)

Granules India Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Non-Current Assets arrow
3,533.26 5,343.00 519.60 10,211.52 1,026.85
Current Assets arrow
3,767.65 2,606.00 1,681.81 7,191.66 881.27
Total Assets arrow
7,682.91 8,578.00 2,326.71 17,723.32 1,983.96
Total Debt* arrow
1,338.13 2,125.00 259.37 5,495.48 26.49
Net Current Assets arrow
1,675.62 984.00 845.94 2,433.38 650.46
Contingent Liabilities arrow
0.93 768.26 19.09 95.72 17.25

Cashflow (₹ Cr)

Granules India Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Cash From Operating Activities arrow
793.25 390.00 205.05 1,652.60 292.17
Cash Flow from Investing Activities arrow
-773.21 -241.00 -409.72 -826.03 -265.94
Cash from Financing Activities arrow
379.29 -54.00 283.07 -38.98 4.10
Net Cash Inflow / Outflow arrow
399.33 95.00 78.39 787.59 30.33

Ratios

Profitability Ratios

 Granules India Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
ROCE (%) arrow
15.74 6.79 29.22 1.24 32.42
ROE (%) arrow
14.34 8.38 29.77 -3.85 25.18
ROA (%) arrow
9.48 4.94 24.77 -2.21 21.93
EBIT Margin (%) arrow
17.23 15.32 20.63 1.66 34.54
Net Margin (%) arrow
11.75 11.23 14.79 -3.93 26.01
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Granules India Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Revenue Growth (%) arrow
24.83 18.37 46.65 0.78 40.90
EBIT Growth (%) arrow
40.39 252.26 62.13 -70.53 124.50
Net Profit Growth (%) arrow
38.13 377.85 89.49 -1,383.43 104.15
EPS Growth (%) arrow
34.88 1,001.33 78.60 -484.84 42.32
Book Value Growth (%) arrow
27.49 13.47 144.31 0.33 26.03

Valuation Ratios

 Granules India Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Price / Earnings arrow
31.92 87.62 89.06 -86.26 67.25
Price / Book Value arrow
4.70 6.94 19.42 3.37 15.05
Dividend Yield (%) arrow
0.21 0.00 0.10 0.00 0.08
EV/EBITDA arrow
18.35 47.12 57.71 30.82 47.51
Market Cap (₹ Cr) arrow
15,391.88 19,071.62 12,753.19 18,108.89 20,944.75

Solvency Ratios

 Granules India Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Debt to Equity arrow
0.06 0.31 0.11 0.53 0.02
Short term debt to equity ratio arrow
0.20 0.09 0.05 0.09 0.02
Current Ratio arrow
1.80 1.61 2.01 1.51 3.82
Quick Ratio arrow
1.00 1.06 1.14 0.87 2.82
Interest Coverage arrow
8.89 3.13 10.09 0.53 141.16

Operating Efficiency Ratios

 Granules India Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Debtors to sales (%) arrow
16.15 16.50 26.28 23.44 24.80
Asset Turnover arrow
0.81 0.43 1.66 0.55 0.83
Receivable days arrow
33.72 58.75 40.13 78.20 88.98
Inventory Days arrow
54.92 75.82 60.29 93.30 56.04
Payable days arrow
136.11 186.21 232.47 226.14 99.95
Cash Conversion Cycle arrow
-47.47 -51.64 -132.04 -54.64 45.07
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...